Judging by the spate of recent announcements, the year ahead looks set to be a tumultuous one for BASF.
Around 700,000 people worldwide die every year from bacteria that have developed resistance to antibiotics.
When the Australian government announced in 2016 it was planning to change the way it regulated chemicals, the announcement was met with almost universal approval.
Epileptic seizures could one day be stopped in their tracks – or even prevented before they have got started, researchers reported at the AAAS meeting in Austin, Texas, in February 2018.
Manufacturers weathered a turbulent 2017, with Brexit uncertainty and questions around productivity just two of the challenges thrown at them.
3D printing, otherwise known as additive manufacturing, uses computer-aided design (CAD) software or 3D object scanners to deposit – or add – melted or partly melted material in layers to form complex shapes.
Blockbuster drugs, formerly the main focus of the pharma industry, are becoming ever rarer, as the industry shifts to more niche therapeutics.
Discovered in 2012, the DNA scissors enzyme CRISPR-Cas9 has become an important tool in gene editing.